Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Frank

Showing results (851-860 of 995) with videos related to

Pageof 100
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2008
Parkin deficiency increases vulnerability to inflammation-related nigral degenerationTamy C Frank-Cannon, Thi Tran, Kelly A Ruhn, et al.
Genomics|June 5, 2004
Genetic regulation of endotoxin-induced airway diseaseDonald N Cook, Shuibang Wang, Yonghong Wang, et al.
Brain : a Journal of Neurology|July 3, 2018
CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosisEva Janzen, Natalia Mendoza-Ferreira, Seyyedmohsen Hosseinibarkooie, et al.
Science Translational Medicine|April 22, 2026
Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of <i>HNRNPH2</i>-related neurodevelopmental disorderAne Korff, Xiaojing Yang, Ozan Ozdemir, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2017
SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damageMohini Jangi, Christina Fleet, Patrick Cullen, et al.
Genome Biology|November 14, 2002
Within the fold: assessing differential expression measures and reproducibility in microarray assaysIvana V Yang, Emily Chen, Jeremy P Hasseman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of <i>HNRNPH2</i>-related neurodevelopmental disorderAne Korff, Xiaojing Yang, Ozan Ozdemir, et al.
Science Advances|August 22, 2025
An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALSJacob Neeves, Marija Petrić Howe, Oliver J Ziff, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 3, 2014
Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primatesFrank Rigo, Seung J Chun, Daniel A Norris, et al.
Human Brain Mapping|December 25, 2024
Therapeutic DBS for OCD Suppresses the Default Mode NetworkNatalya Slepneva, Genevieve Basich-Pease, Lee Reid, et al.
Pageof 100

Showing results (851-860 of 995) with videos related to

Sort By:
Pageof 100
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2008
Parkin deficiency increases vulnerability to inflammation-related nigral degenerationTamy C Frank-Cannon, Thi Tran, Kelly A Ruhn, et al.
Genomics|June 5, 2004
Genetic regulation of endotoxin-induced airway diseaseDonald N Cook, Shuibang Wang, Yonghong Wang, et al.
Brain : a Journal of Neurology|July 3, 2018
CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosisEva Janzen, Natalia Mendoza-Ferreira, Seyyedmohsen Hosseinibarkooie, et al.
Science Translational Medicine|April 22, 2026
Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of <i>HNRNPH2</i>-related neurodevelopmental disorderAne Korff, Xiaojing Yang, Ozan Ozdemir, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2017
SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damageMohini Jangi, Christina Fleet, Patrick Cullen, et al.
Genome Biology|November 14, 2002
Within the fold: assessing differential expression measures and reproducibility in microarray assaysIvana V Yang, Emily Chen, Jeremy P Hasseman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of <i>HNRNPH2</i>-related neurodevelopmental disorderAne Korff, Xiaojing Yang, Ozan Ozdemir, et al.
Science Advances|August 22, 2025
An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALSJacob Neeves, Marija Petrić Howe, Oliver J Ziff, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 3, 2014
Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primatesFrank Rigo, Seung J Chun, Daniel A Norris, et al.
Human Brain Mapping|December 25, 2024
Therapeutic DBS for OCD Suppresses the Default Mode NetworkNatalya Slepneva, Genevieve Basich-Pease, Lee Reid, et al.
Pageof 100